Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06083012Active Not Recruiting

Clinical and Healthcare Economic OutcoMes From ReAl-worlD Use in Europe of an AI Software During AF Ablation

Role: lead

NCT06056271Recruiting

Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

Role: lead

NCT05477147Not ApplicableCompleted

Re-Ablation Using a Tailored Approach Targeting EGM-Dispersion

Role: lead

NCT04702451Not ApplicableCompleted

Tailored vs. Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Role: lead

NCT06825104Recruiting

Long-Term Evaluation of TAILORED Vs Anatomical Ablation Strategy for Persistent Atrial Fibrillation

Role: lead

NCT05362656Not ApplicableCompleted

AutoMatic disPERsion Tagging Function Preliminary Evaluation

Role: lead

All 6 trials loaded